Gc group specific protein Macrophage Activating Factor (GcMAF): Immuno-modulating properties in Health
This type of glycoprotein is naturally found in the human body; it has received extensive interest by the scientific community, since some original clinical research was published by Dr Nobuto Yamamoto, a Japanese doctor, in 1990s.
Several studies have been published since, supporting the view that this protein has the capacity to improve a person’s immune response to inflammation, by raising the performance of macrophages (Grk. “big-eaters”), cells known as destroyers of various ‘invaders’ and initiating T-cell response in the immune system, e.g. in allergies and various so-called “autoimmune” disorders.
Some authorities have been critical, raising questions about methodological flaws in some studies, most of the studies have involved small numbers of patients – more research is needed.
The presence of this protein in nature has little financial attraction for the pharmaceutical industry, mainstream Medicine is mostly focused on the use of medications to combat disease.
The use of GcMAF is not approved by FDA in the USA or MHRA in England – its use is described as “unlicensed” and hence “experimental”. It requires fully informed consent, although there have been no serious safety concerns from its use.
GcMAF has the potential for several clinical applications – these include cancer, chronic fatigue, asthma and other forms of chronic inflammation and so-called “autoimmune” disorders.
There are very few manufacturers, who produce reliable GcMAF (oral and injectable).
Please carry out your own research, along with the information you have received from The Burghwood Clinic.
Disclaimer: GcMAF is prescribed to help improve a person’s immune system and quality of life, not to reverse any specific diagnosis, condition or disease; it is not used to replace any conventional therapy such as medications used in oncology, paediatric or psychiatric professional care.
Contact us if you have further questions or to make an appointment for a consultation.